REG - Coca-Cola EP PLC - Update statement on 2025 AGM voting results

Coca-Cola Europacific PartnersAnnouncement

Yesterday 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251121:nRSU5865Ia&default-theme=true

RNS Number : 5865I  Coca-Cola Europacific Partners plc  21 November 2025

21 November 2025

Coca-Cola Europacific Partners plc

("the Company")

Update statement on 2025 Annual General Meeting voting results

At the Company's 2025 Annual General Meeting ("AGM") held on 22 May 2025, all
resolutions were successfully passed with the requisite majority of votes.
However, in respect of resolution 24 ("Rule 9 Waiver Resolution"), we
acknowledge that a number of our shareholders did not support the resolution
(of votes cast, 74.95% voted in favour).

The Rule 9 Waiver Resolution related to the approval by independent
shareholders of a waiver obtained from the Panel on Takeovers and Mergers in
respect of an obligation that could arise on Olive Partners, S.A. ("Olive"),
or any persons acting in concert with Olive, to make a general offer for all
the issued ordinary share capital of the Company following any increase in the
percentage of shares held by Olive, or any persons acting in concert with
Olive, resulting from the exercise by the Company of the authority to purchase
its own shares pursuant to resolutions 27 and 28 (which received approval from
99.22% and 98.22% of those voting respectively).

The Board believes that it is in the best interests of shareholders that the
Company has the flexibility to return value to shareholders through future
buyback programmes as demonstrated in our commitment to return up to €1bn to
shareholders as part of the share buyback programme announced on 14 February
2025. If the Rule 9 Waiver Resolution had not been approved, the Company would
not have been able to effect such buyback programmes as explained in the 2025
Notice of AGM and also in the Letter to Shareholders issued via RNS on 12 May
2025.

Since the AGM, the Company has continued to engage where appropriate with its
shareholders on the rationale and merits of the Rule 9 Waiver Resolution, and
to address any concerns they may have. The Board believes that share buybacks
represent an attractive means of returning capital to shareholders and, as
such, they form a core component of the Company's capital allocation
framework. The Board recognises, and acknowledges, shareholder concerns around
the use of Rule 9 waivers in the context of share buybacks and continues to
evaluate other means of returning capital to shareholders. The Board is
grateful for the engagement of shareholders.

CONTACTS

 Company Secretariat  Investor Relations   Media Relations

 Clare Wardle         Sarah Willett        Shanna Wendt

 T +44 20 7355 8406   T +44 7970 145 218   T +44 7976 595 168

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods
companies. We make, move and sell some of the world's most loved brands -
serving nearly 600 million consumers and helping over 4 million customers
across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an
expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock
Exchange and on the Spanish Stock Exchanges, and a constituent of both the
Nasdaq 100 and FTSE 100 indices, trading under the symbol CCEP (ISIN No.
GB00BDCPN049).

For more information about CCEP, please visit www.cocacolaep.com & follow
CCEP on LinkedIn

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGMEADFFAEFSFFA



            Copyright 2019 Regulatory News Service, all rights reserved